{"role": "assistant", "content": null, "function_call": {"name": "classify_risks_framework", "arguments": "{\"sorted_risks\":[{\"name\":\"Potential misinterpretation of wastewater data leading to premature public health actions\",\"category\":\"Participation\",\"confidence\":\"Medium\"},{\"name\":\"Possibility of estimating disease prevalence based on wastewater testing\",\"category\":\"Leadership\",\"confidence\":\"High\"},{\"name\":\"Reliance on wastewater testing to detect population-level prevalence of SARS-CoV-2\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Uncertainty in viral titer estimates from wastewater could lead to inaccurate calculations of disease prevalence\",\"category\":\"Vision&Priorities\",\"confidence\":\"Low\"},{\"name\":\"Limitations in testing capacity and criteria for testing could lead to an underestimate of clinically confirmed cases\",\"category\":\"Capacity Development\",\"confidence\":\"Medium\"},{\"name\":\"A significant fraction of cases may go undetected with current testing algorithms, especially asymptomatic individuals\",\"category\":\"Capacity Development\",\"confidence\":\"High\"},{\"name\":\"Incomplete quantification of viral titers due to lack of investigation on recovery rates for each step in the process\",\"category\":\"Capacity Development\",\"confidence\":\"Medium\"},{\"name\":\"Variations in PMMoV concentrations across samples without understanding the stability over time for the catchment population\",\"category\":\"Visions&Priorities\",\"confidence\":\"Low\"},{\"name\":\"High prevalence of SARS-CoV-2 in wastewater samples indicating potential community spread\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Lack of data on viral shedding in stool over the clinical course of the disease\",\"category\":\"Capacity Development\",\"confidence\":\"Medium\"},{\"name\":\"Reliance on protocol without validation using expensive commercial kits\",\"category\":\"Visions&Priorities\",\"confidence\":\"Medium\"},{\"name\":\"Potential presence of viral genomes in sewage\",\"category\":\"Capacity Development\",\"confidence\":\"Medium\"},{\"name\":\"Uncertainty in viral load estimates in sewage and stool\",\"category\":\"Vision&Priorities\",\"confidence\":\"High\"},{\"name\":\"Large variation in viral load in stool samples\",\"category\":\"Capacity Development\",\"confidence\":\"Medium\"},{\"name\":\"Variation in viral signal degradation during storage at 4\u00b0C\",\"category\":\"Capacity Development\",\"confidence\":\"Low\"},{\"name\":\"Unstable sewage flow rate impacted by factors including rainstorms\",\"category\":\"Visions&Priorities\",\"confidence\":\"Medium\"},{\"name\":\"Variation in PMMoV levels across samples with a standard deviation of 1.34 CT units\",\"category\":\"Capacity Development\",\"confidence\":\"Low\"},{\"name\":\"Limited access to testing for sars-cov-2 in the united states\",\"category\":\"Capacity Development\",\"confidence\":\"High\"},{\"name\":\"Inadequate surveillance of disease outbreaks in residential communities\",\"category\":\"Participation\",\"confidence\":\"High\"},{\"name\":\"Emergence of new variants of sars-cov-2\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Mixing measles, mumps, and rubella mmr vaccine to test for broad-spectrum viral immunity\",\"category\":\"Visions&Priorities\",\"confidence\":\"Medium\"},{\"name\":\"Use of drugs with potential side effects for covid-19 treatment\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Knowledge gaps in understanding covid-19 and its differences from other viruses\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Misunderstanding of environmental stability\",\"category\":\"Visions&Priorities\",\"confidence\":\"Medium\"},{\"name\":\"Children at risk of severe symptoms due to kawasaki syndrome and artery diseases.\",\"category\":\"Family\",\"confidence\":\"Medium\"},{\"name\":\"Higher infection rate in younger population due to insufficient social distancing and mask protection.\",\"category\":\"Leadership\",\"confidence\":\"Medium\"},{\"name\":\"Creation of pathogenic strains through synthetic biology\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Identification of patient zero\",\"category\":\"Accountability\",\"confidence\":\"Low\"},{\"name\":\"Mutations leading to increased infectivity and immune evasion\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Unclear research on virus origin\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Potential intermediate hosts in animal species\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Lack of cross-border collaboration leading to uncoordinated efforts in disease control.\",\"category\":\"Leadership\",\"confidence\":\"High\"},{\"name\":\"Lack of funding and weak programmatic capacity\",\"category\":\"Leadership\",\"confidence\":\"High\"},{\"name\":\"Call for strengthening vector control following the zika epidemic\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Reduction in the number of entomologists working at who\u2019s headquarters in geneva\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Complacency and lack of investment in vector control\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Lack of political will and central coordination\",\"category\":\"Leadership\",\"confidence\":\"High\"},{\"name\":\"Geographic expansion of vectors and viruses through globalization and urbanization\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Lack of investment in aedes vector control leading to ineffective prevention of aedes-borne epidemics\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Relaxation of disease control programs in non-endemic regions\",\"category\":\"Participation\",\"confidence\":\"Medium\"},{\"name\":\"Neglect of surveillance activities leading to increase in hat cases\",\"category\":\"Leadership\",\"confidence\":\"High\"},{\"name\":\"Scaling down of tsetse control campaigns leading to increase in hat cases\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Delay in eliminating transmission of hat by 2030\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Chagas disease and leishmaniasis transmission\",\"category\":\"Organization\",\"confidence\":\"Low\"},{\"name\":\"Reduction in prevalence of human microfilariae infections from 70% to negligible levels is reported.\",\"category\":\"Vision&Priorities\",\"confidence\":\"Low\"},{\"name\":\"Onchocerciasis elimination program of the americas oepa launched in 1991, and the african programme for onchocerciasis control apoc established in 19 african countries.\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Success of vector control against chagas disease in the southern cone initiative sci and similar initiatives in central america and andean pact countries.\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Success of vector control in onchocerciasis control programme ocp in africa.\",\"category\":\"Organizations\",\"confidence\":\"High\"},{\"name\":\"Sociopolitical instability and limited socioeconomic development in malaria-endemic areas\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"},{\"name\":\"Rebound of malaria transmission after intervention cessation\",\"category\":\"Visions&Priorities\",\"confidence\":\"High\"}]}"}}